BIOMAT Database Logo BIOMAT Database Logo

A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. 1978

W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine

Related Publications

W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridine.
April 1994, Cancer research,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
October 1996, Cancer research,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.
February 1990, Journal of chemotherapy (Florence, Italy),
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Clinical evaluation of the pyrimidine nucleosides 5-fluoro-2'-deoxyuridine and 5-iodo-2'-deoxyuridine.
July 1962, Cancer chemotherapy reports,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Enzymatic conversion of 5-fluoro-2'-deoxyuridine to 5-fluorouracil or 5-fluoro-2'-deoxyuridine 5'-monophosphate in human tissues.
January 1990, Anticancer research,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
FURTHER CLINICAL COMPARISON BETWEEN 5-FLUOROURACIL (5-FU) AND 5-FLUORO-2' -DEOXYURIDINE (5-FUDR).
October 1963, Cancer chemotherapy reports,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
The clinical evaluation of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in solid tumors in adults: a progress report.
February 1960, Cancer chemotherapy reports,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridine.
September 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
November 1967, Cancer research,
W D Ensminger, and A Rosowsky, and V Raso, and D C Levin, and M Glode, and S Come, and G Steele, and E Frei
THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.
January 1964, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!